| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
Biosynthesis via Heme Oxygenase-1 in Human Endothelial CellsFrom the Department of Medicine and Aging (L.D.F., M.D., A.D.F., T.S., P.P.), "G. dAnnunzio" University, Chieti, Italy; CeSI (L.D.F., M.D., A.D.F., T.S., A. Pandolfi, P.P.), Chieti, Italy; Mario Negri Sud (L.T., A. Piccoli, V.E.), Santa Maria Imbaro, Chieti, Italy; and Departments of Pharmacology and Toxicology (R.A.D.) and Physiology and Biochemistry (F.S.), Queens University, Kingston, Ontario, Canada.
Correspondence to Paola Patrignani, PhD, Sezione di Farmacologia, Dipartimento di Medicina e Scienze dellInvecchiamento, Università "G. dAnnunzio", Via dei Vestini, 31, 66100 Chieti, Italy. E-mail ppatrignani{at}unich.it
Cyclooxygenase (COX)-2 is among the endothelial genes upregulated by uniform laminar shear stress (LSS), characteristically associated with atherosclerotic lesion-protected areas. We have addressed whether the induction of COX-2–dependent prostanoids in endothelial cells by LSS plays a role in restraining endothelial tumor necrosis factor (TNF)-
generation, a proatherogenic cytokine, through the induction of heme oxygenase-1 (HO)-1, an antioxidant enzyme. In human umbilical vein endothelial cells (HUVECs) exposed to steady LSS of 10 dyn/cm2 for 6 hours, COX-2 protein was significantly induced, whereas COX-1 and the downstream synthases were not significantly modulated. This was associated with significant (P<0.05) increase of 6-keto-prostaglandin (PG)F1
(the hydrolysis product of prostacyclin), PGE2, and PGD2. In contrast, TNF-
released in the medium in 6 hours (3633±882 pg) or detected in cells lysates (1091±270 pg) was significantly (P<0.05) reduced versus static condition (9100±2158 and 2208±300 pg, respectively). Coincident induction of HO-1 was detected. The finding that LSS-dependent reduction of TNF-
generation and HO-1 induction were abrogated by the selective inhibitor of COX-2 NS-398, the nonselective COX inhibitor aspirin, or the specific prostacyclin receptor (IP) antagonist RO3244794 illuminates the central role played by LSS-induced COX-2–dependent prostacyclin in restraining endothelial inflammation. Carbacyclin, an agonist of IP, induced HO-1. Similarly to inhibition of prostacyclin biosynthesis or activity, the novel imidazole-based HO-1 inhibitor QC15 reversed TNF-
reduction by LSS. These findings suggest that inhibition of COX-2–dependent prostacyclin might contribute to acceleration of atherogenesis in patients taking traditional nonsteroidal antiinflammatory drugs (NSAIDs) and NSAIDs selective for COX-2 through downregulation of HO-1, which halts TNF-
generation in human endothelial cells.
Key Words: cyclooxygenase endothelial cells prostaglandins prostanoids shear stress tumor necrosis factor-
This article has been cited by other articles:
![]() |
M. D. Salvado, A. Alfranca, A. Escolano, J. Z. Haeggstrom, and J. M. Redondo COX-2 Limits Prostanoid Production in Activated HUVECs and Is a Source of PGH2 for Transcellular Metabolism to PGE2 by Tumor Cells Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1131 - 1137. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |